Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India
Abstract This study employs repeated, large panels of serological surveys to document rapid and substantial waning of SARS-CoV-2 antibodies at the population level and to calculate the extent to which infection and vaccination separately contribute to seroprevalence estimates. Four rounds of serolog...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-01-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-023-50338-3 |
| _version_ | 1827327816924921856 |
|---|---|
| author | T. S. Selvavinayagam Anavarathan Somasundaram Jerard Maria Selvam P. Sampath V. Vijayalakshmi C. Ajith Brabhu Kumar Sudharshini Subramaniam Parthipan Kumarasamy S. Raju R. Avudaiselvi V. Prakash N. Yogananth Gurunathan Subramanian A. Roshini D. N. Dhiliban Sofia Imad Vaidehi Tandel Rajeswari Parasa Stuti Sachdeva Sabareesh Ramachandran Anup Malani |
| author_facet | T. S. Selvavinayagam Anavarathan Somasundaram Jerard Maria Selvam P. Sampath V. Vijayalakshmi C. Ajith Brabhu Kumar Sudharshini Subramaniam Parthipan Kumarasamy S. Raju R. Avudaiselvi V. Prakash N. Yogananth Gurunathan Subramanian A. Roshini D. N. Dhiliban Sofia Imad Vaidehi Tandel Rajeswari Parasa Stuti Sachdeva Sabareesh Ramachandran Anup Malani |
| author_sort | T. S. Selvavinayagam |
| collection | DOAJ |
| description | Abstract This study employs repeated, large panels of serological surveys to document rapid and substantial waning of SARS-CoV-2 antibodies at the population level and to calculate the extent to which infection and vaccination separately contribute to seroprevalence estimates. Four rounds of serological surveys were conducted, spanning two COVID waves (October 2020 and April–May 2021), in Tamil Nadu (population 72 million) state in India. Each round included representative populations in each district of the state, totaling ≥ 20,000 persons per round. State-level seroprevalence was 31.5% in round 1 (October–November 2020), after India’s first COVID wave. Seroprevalence fell to 22.9% in round 2 (April 2021), a roughly one-third decline in 6 months, consistent with dramatic waning of SARS-Cov-2 antibodies from natural infection. Seroprevalence rose to 67.1% by round 3 (June–July 2021), with infections from the Delta-variant induced second COVID wave accounting for 74% of the increase. Seroprevalence rose to 93.1% by round 4 (December 2021–January 2022), with vaccinations accounting for 63% of the increase. Antibodies also appear to wane after vaccination. Seroprevalence in urban areas was higher than in rural areas, but the gap shrunk over time (35.7 v. 25.7% in round 1, 89.8% v. 91.4% in round 4) as the epidemic spread even in low-density rural areas. |
| first_indexed | 2024-03-07T15:07:53Z |
| format | Article |
| id | doaj.art-1887d6fcf99e4a5eab04d3290c113d87 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-03-07T15:07:53Z |
| publishDate | 2024-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-1887d6fcf99e4a5eab04d3290c113d872024-03-05T18:47:28ZengNature PortfolioScientific Reports2045-23222024-01-0114111110.1038/s41598-023-50338-3Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, IndiaT. S. Selvavinayagam0Anavarathan Somasundaram1Jerard Maria Selvam2P. Sampath3V. Vijayalakshmi4C. Ajith Brabhu Kumar5Sudharshini Subramaniam6Parthipan Kumarasamy7S. Raju8R. Avudaiselvi9V. Prakash10N. Yogananth11Gurunathan Subramanian12A. Roshini13D. N. Dhiliban14Sofia Imad15Vaidehi Tandel16Rajeswari Parasa17Stuti Sachdeva18Sabareesh Ramachandran19Anup Malani20Directorate of Public Health and Preventative Medicine, Government of Tamil NaduInstitute of Community Medicine, Madras Medical CollegeDirectorate of Public Health and Preventative Medicine, Government of Tamil NaduDirectorate of Public Health and Preventative Medicine, Government of Tamil NaduDirectorate of Public Health and Preventative Medicine, Government of Tamil NaduDirectorate of Public Health and Preventative Medicine, Government of Tamil NaduInstitute of Community Medicine, Madras Medical CollegeDirectorate of Public Health and Preventative Medicine, Government of Tamil NaduDirectorate of Public Health and Preventative Medicine, Government of Tamil NaduDirectorate of Public Health and Preventative Medicine, Government of Tamil NaduDirectorate of Public Health and Preventative Medicine, Government of Tamil NaduDirectorate of Public Health and Preventative Medicine, Government of Tamil NaduDirectorate of Public Health and Preventative Medicine, Government of Tamil NaduDirectorate of Public Health and Preventative Medicine, Government of Tamil NaduDirectorate of Public Health and Preventative Medicine, Government of Tamil NaduArtha GlobalUniversity of ManchesterArtha GlobalWorld BankUniversity of CaliforniaUniversity of ChicagoAbstract This study employs repeated, large panels of serological surveys to document rapid and substantial waning of SARS-CoV-2 antibodies at the population level and to calculate the extent to which infection and vaccination separately contribute to seroprevalence estimates. Four rounds of serological surveys were conducted, spanning two COVID waves (October 2020 and April–May 2021), in Tamil Nadu (population 72 million) state in India. Each round included representative populations in each district of the state, totaling ≥ 20,000 persons per round. State-level seroprevalence was 31.5% in round 1 (October–November 2020), after India’s first COVID wave. Seroprevalence fell to 22.9% in round 2 (April 2021), a roughly one-third decline in 6 months, consistent with dramatic waning of SARS-Cov-2 antibodies from natural infection. Seroprevalence rose to 67.1% by round 3 (June–July 2021), with infections from the Delta-variant induced second COVID wave accounting for 74% of the increase. Seroprevalence rose to 93.1% by round 4 (December 2021–January 2022), with vaccinations accounting for 63% of the increase. Antibodies also appear to wane after vaccination. Seroprevalence in urban areas was higher than in rural areas, but the gap shrunk over time (35.7 v. 25.7% in round 1, 89.8% v. 91.4% in round 4) as the epidemic spread even in low-density rural areas.https://doi.org/10.1038/s41598-023-50338-3 |
| spellingShingle | T. S. Selvavinayagam Anavarathan Somasundaram Jerard Maria Selvam P. Sampath V. Vijayalakshmi C. Ajith Brabhu Kumar Sudharshini Subramaniam Parthipan Kumarasamy S. Raju R. Avudaiselvi V. Prakash N. Yogananth Gurunathan Subramanian A. Roshini D. N. Dhiliban Sofia Imad Vaidehi Tandel Rajeswari Parasa Stuti Sachdeva Sabareesh Ramachandran Anup Malani Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India Scientific Reports |
| title | Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India |
| title_full | Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India |
| title_fullStr | Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India |
| title_full_unstemmed | Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India |
| title_short | Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India |
| title_sort | contribution of infection and vaccination to population level seroprevalence through two covid waves in tamil nadu india |
| url | https://doi.org/10.1038/s41598-023-50338-3 |
| work_keys_str_mv | AT tsselvavinayagam contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT anavarathansomasundaram contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT jerardmariaselvam contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT psampath contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT vvijayalakshmi contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT cajithbrabhukumar contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT sudharshinisubramaniam contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT parthipankumarasamy contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT sraju contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT ravudaiselvi contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT vprakash contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT nyogananth contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT gurunathansubramanian contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT aroshini contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT dndhiliban contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT sofiaimad contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT vaidehitandel contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT rajeswariparasa contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT stutisachdeva contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT sabareeshramachandran contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia AT anupmalani contributionofinfectionandvaccinationtopopulationlevelseroprevalencethroughtwocovidwavesintamilnaduindia |